Director, Medical Payer Strategy

Company Description

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

Job Description

Drives the development and execution of the market access payer, GPO, IDN, guidelines, and clinical pathway scientific strategies within the key Oncology therapeutic areas across all access decision-makers. Works cross-functionally in a highly matrixed environment to support scientific and market access needs of brand and market access commercial, HEOR, and medical affairs.  Represents Medical Payer Strategy (MPS), both internally and externally, as the subject matter expert in translating the scientific and HEOR data with cross-functional stakeholders (Commercial, Market Access,  HEOR, Clinical Development, etc). Represents V&A Oncology MPS on key cross-functional teams to communicate and integrate medical access evidence needs into the gaps assessment process.    

• Development and execution of the medical affairs access/HCDM strategy and tactics across all oncology access channels (payer, distribution, IDN, GPO, Clinical Pathways, guidelines)
• Lead Oncology Clinical Core Team in the development and execution of clinical guidelines and pathways scientific plans.
• Actively participate in relevant cross-functional (e.g., Commercial, Market Access, HEOR, Clinical Development, etc) teams to provide market access scientific and pharmaeconomic subject matter expertise.
• Actively participate in global gaps assessment development and provide medical market access input into Integrated Evidence Plans via IEST, presents medical access considerations at VAT and AST
• Lead the development of strategic resources and provide relevant scientific and technical training.
• Lead HCDM-focused development of medical pharmacoeconomic materials, medical education programs, advisories, and HCDM symposia. Ma